Fluvoxamine improves affect lability in borderline personality disorder

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1373, 2003-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Opioid addiction and borderline personality disorder

American Journal on Addictions, Vol. 27, Iss. 1, 2018-01 ,pp. : 54-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Tolerability of Pharmacotherapies for Borderline Personality Disorder

By Bellino Silvio Paradiso Erika Bogetto Filippo

CNS Drugs, Vol. 22, Iss. 8, 2008-01 ,pp. : 671-692

Adis International

Access to resources Recommend Favorite

Olanzapine vs Aripiprazole in the Management of Borderline Personality Disorder

By S. Shafti Saeed Kaviani Hamid

Current Psychopharmacology, Vol. 3, Iss. 2, 2014-08 ,pp. : 132-136

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of Borderline Personality Disorder: A Systematic Review

Current Medicinal Chemistry, Vol. 18, Iss. 22, 2011-08 ,pp. : 3322-3329

Bentham Science Publishers

Access to resources Recommend Favorite

Olanzapine vs Aripiprazole in the Management of Borderline Personality Disorder

Current Psychopharmacology, Vol. 3, Iss. 2, 2014-08 ,pp. : 132-136

Bentham Science Publishers

Access to resources Recommend Favorite